Filing Details
XBiotech Inc. (NASDAQ:XBIT) filed a Form 8-K with the Securities and Exchange Commission on October 26, 2026, disclosing a material event.
8k filedNASDAQ:XBIT
XBiotech Inc. (XBIT) Reports Material Event to SEC
XBiotech Inc. (NASDAQ:XBIT) filed a Form 8-K with the Securities and Exchange Commission on October 26, 2026, disclosing a material event.
At publication ·
What changed
XBiotech Inc. (NASDAQ:XBIT) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- XBiotech Inc. filed a Form 8-K with the SEC on October 26, 2026, disclosing a material event to shareholders.
- The stock trades at $1.85 with a market capitalization of $76.8 million.
- 8-K filings report material events such as leadership changes, acquisitions, asset sales, or financial guidance changes.
- The article does not specify what material event XBiotech disclosed in its filing.
Market Context
XBiotech Inc.'s stock currently trades at $1.85 with a market capitalization of $76.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for XBiotech Inc.'s stock.
All SEC filings for XBiotech Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View XBIT Stock Page
Frequently Asked Questions
Where can I read XBIT's SEC filings?
Browse all filings on our XBIT SEC filings page.
What types of SEC filings does XBiotech Inc. file?
Public companies like XBiotech Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.